EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pancreatic Head Cancer Masquerading as Distal Cholangiocarcinoma: Diagnostic Challenges, Tumor Characteristics, and Oncologic Outcomes

Kenta Aso iD, Ryuji Yoshioka, Atsushi Takahashi, Shoichi Irie iD, Yoshinori Takeda, Yoshihiro Hirata, Takaaki Kato, Hirofumi Ichida, Yoshihito Kotera, Yoshihiro Mise, Yuki Fukumura iD, Akio Saiura

Cancers · 08.03.2026 · 18 (5) · 870

DOI: 10.3390/cancers18050870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 08.03.2026. Verfasst von Kenta Aso und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Differentiating pancreatic head cancer (PHC) from distal cholangiocarcinoma (dCCA) remains clinically challenging and directly influences treatment strategy. This study evaluates the clinicopathologic features and outcomes of patients with PHC who were preoperatively designated as dCCA.

Methods

We retrospectively analyzed patients undergoing pancreatoduodenectomy for suspected dCCA or PHC from 2019 to 2023. Patients were stratified by pre- and postoperative diagnoses into three groups: confirmed dCCA (B-B), confirmed PHC (P-P), and dCCA reclassified as PHC (B-P). Clinicopathologic features, perioperative outcomes, and survival were compared.

Results

This analysis included 159 patients, B-B = 31, P-P = 115, and B-P = 13. Despite a more advanced stage, a lower R0 rate (p = 0.043), and unplanned portal vein resection confined to B-P (p < 0.001), overall and recurrence-free survival were comparable to P-P (p = 0.363 and 0.183). In multivariable Cox analysis, B-P remained an independent favorable prognostic factor for overall survival (Hazard ratio 0.137, p = 0.020).

Conclusions

Approximately one-third of cases initially diagnosed as dCCA were ultimately PHC. These PHC cases mimicking dCCA demonstrated comparable or even superior survival, suggesting a biologically indolent subset. Refinement of diagnostic criteria and integrated clinicopathologic assessment are essential for optimizing preoperative management strategies.

Schlagwörter

Stichwörter der Autor:innen

distal cholangiocarcinomapancreatic ductal adenocarcinomapancreatic head cancerpreoperative diagnosissurgical outcomes

Autor:innen und Institutionen

  • Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
  • Department of Human Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

ORCID-Profile: Kenta Aso, Shoichi Irie, Yuki Fukumura

Zitieren

APA

Aso, K., Yoshioka, R., Takahashi, A., Irie, S., Takeda, Y., Hirata, Y., Kato, T., Ichida, H., Kotera, Y., Mise, Y., Fukumura, Y., & Saiura, A. (2026). Pancreatic Head Cancer Masquerading as Distal Cholangiocarcinoma: Diagnostic Challenges, Tumor Characteristics, and Oncologic Outcomes. Cancers, 18(5), 870. https://doi.org/10.3390/cancers18050870

Vancouver

Aso K, Yoshioka R, Takahashi A, Irie S, Takeda Y, Hirata Y, et al. Pancreatic Head Cancer Masquerading as Distal Cholangiocarcinoma: Diagnostic Challenges, Tumor Characteristics, and Oncologic Outcomes. Cancers. 2026;18(5):870. doi:10.3390/cancers18050870

BibTeX
@article{Aso2026,
  author = {Aso, Kenta and Yoshioka, Ryuji and Takahashi, Atsushi and Irie, Shoichi and Takeda, Yoshinori and Hirata, Yoshihiro and Kato, Takaaki and Ichida, Hirofumi and Kotera, Yoshihito and Mise, Yoshihiro and Fukumura, Yuki and Saiura, Akio},
  title = {Pancreatic Head Cancer Masquerading as Distal Cholangiocarcinoma: Diagnostic Challenges, Tumor Characteristics, and Oncologic Outcomes},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {870},
  doi = {10.3390/cancers18050870}
}
Kostenlos starten →